Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
5 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Antibody Response to COVID-19 mRNA Vaccine in Patients With Lung Cancer After Primary Immunization and Booster: Reactivity to the SARS-CoV-2 WT Virus and Omicron Variant.
J Clin Oncol. 2022 Nov 20;40(33):3808-3816. doi: 10.1200/JCO.21.02986. Epub 2022 Jun 27.
J Clin Oncol. 2022.
PMID: 35759727
Free PMC article.
Antibody response to SARS-CoV-2 mRNA vaccine in lung cancer patients: Reactivity to vaccine antigen and variants of concern.
Valanparambil R, Carlisle J, Linderman S, Akthar A, Millett RL, Lai L, Chang A, McCook A, Switchenko J, Nasti T, Saini M, Andreas Wieland AW, Manning K, Ellis M, Moore K, Foster S, Floyd K, Davis-Gardner M, Viswanadh Edara V, Patel M, Steur C, Nooka A, Green F, Johns M, O Brein F, Shanmugasundaram U, Zarnitsyna V, Ahmed H, Nyhoff L, Mantus G, Garett M, Edupuganti S, Behra M, Antia R, Wrammert J, Suthar M, Dhodapkar M, Ramalingam S, Ahmed R.
Valanparambil R, et al. Among authors: millett rl.
medRxiv [Preprint]. 2022 Jan 23:2022.01.03.22268599. doi: 10.1101/2022.01.03.22268599.
medRxiv. 2022.
PMID: 35018383
Free PMC article.
Updated.
Preprint.
Item in Clipboard
Two distinct histological Richter's transformations 23 years apart in a patient with chronic lymphocytic leukaemia.
Thebo U, Millett RL, Elkon J, Haroun F.
Thebo U, et al. Among authors: millett rl.
BMJ Case Rep. 2018 Oct 8;2018:bcr2018225893. doi: 10.1136/bcr-2018-225893.
BMJ Case Rep. 2018.
PMID: 30301728
Free PMC article.
Item in Clipboard
Directed Therapies in Anaplastic Lymphoma Kinase-rearranged Non-small Cell Lung Cancer.
Millett RL, Elkon JM, Tabbara IA.
Millett RL, et al.
Anticancer Res. 2018 Sep;38(9):4969-4975. doi: 10.21873/anticanres.12815.
Anticancer Res. 2018.
PMID: 30194140
Review.
Item in Clipboard
Abiraterone is effective and should be considered for the treatment of metastatic castrate-naïve prostate cancer.
Elkon JM, Millett RL, Millado KF, Lin J.
Elkon JM, et al. Among authors: millett rl.
Expert Opin Pharmacother. 2018 Apr;19(5):507-509. doi: 10.1080/14656566.2018.1444028. Epub 2018 Mar 1.
Expert Opin Pharmacother. 2018.
PMID: 29494266
Item in Clipboard
Cite
Cite